Cargando…

The Potential of Tumor Debulking to Support Molecular Targeted Therapies

Tumors may consist of billions of cells, which in malignant cases disseminate and form distant metastases. The large number of tumor cells formed by the high number of cell divisions during tumor progression creates a heterogeneous set of genetically diverse tumor cell clones. For cancer therapy thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oppel, Felix, Görner, Martin, Sudhoff, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314947/ https://www.ncbi.nlm.nih.gov/pubmed/32626653 http://dx.doi.org/10.3389/fonc.2020.00801

Ejemplares similares

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Sensorineural Hearing Loss After Balloon Eustachian Tube Dilatation
por: Todt, Ingo, et al.
Publicado: (2021)

Clinical Phenotypes of Tumors Invading the Rectosigmoid Colon Affecting the Extent of Debulking Surgery and Survival in Advanced Ovarian Cancer
por: Park, Soo Jin, et al.
Publicado: (2021)

Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes
por: Nicholas, Sarah E., et al.
Publicado: (2019)

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy
por: Goon, Peter, et al.
Publicado: (2023)

Prognostic Significance of Systematic Lymphadenectomy in Patients With Optimally Debulked Advanced Ovarian Cancer: A Meta-Analysis
por: Wang, Yizi, et al.
Publicado: (2020)

Intensive Debulking Chemotherapy Improves the Short-Term and Long-Term Efficacy of Anti-CD19-CAR-T in Refractory/Relapsed DLBCL With High Tumor Bulk
por: Lyu, Cuicui, et al.
Publicado: (2021)

Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
por: Bonifacio, Massimiliano, et al.
Publicado: (2022)

Role of Lymphadenectomy During Interval Debulking Surgery Performed After Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
por: He, Minjun, et al.
Publicado: (2021)

Rac1, A Potential Target for Tumor Therapy
por: Liang, Jiaxin, et al.
Publicado: (2021)

An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model
por: Oppel, Felix, et al.
Publicado: (2019)

Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort
por: Feng, Zheng, et al.
Publicado: (2021)

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
por: Lee, Yong Jae, et al.
Publicado: (2022)

Tumor-Associated Macrophages: A Potential Target for Cancer Therapy
por: Tan, Yifan, et al.
Publicado: (2021)

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer
por: Luger, Anna K., et al.
Publicado: (2020)

Anesthetic management for bronchoscopy and debulking of obstructing intratracheal tumor
por: Uma, B., et al.
Publicado: (2015)

Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers
por: Wang, Jie, et al.
Publicado: (2022)

Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy
por: Popper, Helmut, et al.
Publicado: (2021)

The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies
por: Shen, Colette J., et al.
Publicado: (2021)

SPINKs in Tumors: Potential Therapeutic Targets
por: Liao, Chengcheng, et al.
Publicado: (2022)

Stem Cell-Induced Inflammation in Cholesteatoma Is Inhibited by the TLR4 Antagonist LPS-RS
por: Schürmann, Matthias, et al.
Publicado: (2020)

Phenytoin Seizure Prophylaxis Therapy Resulting in Severe Thrombocytopenia After Brain Tumor Debulking Surgery
por: Al Ghamdi, Rawan M., et al.
Publicado: (2020)

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
por: Ghosh, Susmita, et al.
Publicado: (2019)

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation
por: Nelson, Bailey, et al.
Publicado: (2022)

Targeting MYCN in Molecularly Defined Malignant Brain Tumors
por: Borgenvik, Anna, et al.
Publicado: (2021)

Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism
por: Schürmann, Matthias, et al.
Publicado: (2021)

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches
por: Geissler, Klaus
Publicado: (2021)

A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study
por: Gu, Yu, et al.
Publicado: (2021)

Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis
por: Zeng, Siyuan, et al.
Publicado: (2022)

Quinary debulking for epithelial ovarian cancer
por: Edwards, James M., et al.
Publicado: (2012)

Role of hypoxia in the tumor microenvironment and targeted therapy
por: Chen, Gaoqi, et al.
Publicado: (2022)

Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
por: Sørensen, Brita Singers, et al.
Publicado: (2020)

The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic Rhinosinusitis
por: Schürmann, Matthias, et al.
Publicado: (2019)

Improvement of Cancer Immunotherapy by Combining Molecular Targeted Therapy
por: Kawakami, Yutaka, et al.
Publicado: (2013)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
por: Hintelmann, Katharina, et al.
Publicado: (2020)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7s2eocsbf08fntsf2l1l26mo3d